Levy Richard S
- SEC CIK
- 0001454983
In the past year, 2 open-market sale filings worth $7.36M and no purchases.
Current role at each company
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Aug 4, 2026
- KOD Kodiak Sciences Inc.Directoras of Jul 2, 2026
- MDGL Madrigal Pharmaceuticals, Inc.Directoras of Jun 18, 2026
- TARA Protara Therapeutics, Inc.Directoras of Jun 16, 2026
- CNST Constellation Pharmaceuticals IncDirectoras of Jul 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.36M
- 2 filings
- Net
- −$7.36M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Levy Richard S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MDGL Madrigal Pharmaceuticals, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 (view filing) | May 22 | Same day | Levy Richard SDirector | SSale | −5.68K | $515.44 | −$2.93M | −20.5%22.0K after | 12 lots10b5-1 |
| Nov 14, 2025 (view filing) | Nov 13 | 1 day | Levy Richard SDirector | SSale | −8.50K | $520.96 | −$4.43M | −28.6%21.2K after | 14 lots10b5-1 |
| Nov 8, 2024 (view filing) | Nov 7 | 1 day | Levy Richard SDirector | SSale | −5.00K | $350.00 | −$1.75M | −31.2%11.0K after | 10b5-1 |
| Nov 5, 2024 (view filing) | Nov 1 | 4 days | Levy Richard SDirector | SSale | −5.00K | $300.94 | −$1.50M | −31.2%11.0K after | 4 lots10b5-1 |
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Levy Richard SDirector | SSale | −11.0K | $257.48 | −$2.83M | −51.6%10.3K after | 6 lots10b5-1 |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Levy Richard SDirector | SSale | −22.5K | $293.15 | −$6.59M | −71.2%9.10K after | 10 lots |
TARA Protara Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 (view filing) | May 14 | 5 days | Levy Richard SDirector | PPurchase | +20.0K | $3.19 | +$63.8K | +64.5%51.0K after | Amended |